Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation

Phase 3 Withdrawn University of California, Los Angeles Genzyme, a Sanofi Company · collab

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to take a population of lung transplant recipients who meet UCLA criteria for induction chemotherapy with thymoglobulin and prospectively study weather giving the first dose intraoperatively versus postoperatively makes a difference with how patients do during and after lung transplantation.

Timeline

Start: 2006-01
Primary completion: 2009-09
Completion: 2010-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Thymoglobulin	Protein / enzyme biologic	1.5 mg/kg	Intravenous

Indications

No indication recorded.